Fri, Dec 19, 2014, 8:59 AM EST - U.S. Markets open in 31 mins.

Recent

% | $
Quotes you view appear here for quick access.

Ligand Pharmaceuticals Incorporated Message Board

  • long_vrts2 long_vrts2 Feb 11, 2013 11:59 PM Flag

    Report: Promacta effect on platelet function

    Platelets induced by Promacta function similar to those from control pts. This is a very positive finding because it implies that Promacta only changes platelet count but not function, which implies predictable and manageable AE profile:

    Function of eltrombopag-induced platelets compared to platelets from control patients with immune thrombocytopenia.
    Haselboeck J, Kaider A, Pabinger I, Panzer S.
    Source

    Simon Panzer, MD, Department of Blood Group Serology and Transfusion Medicine, Medical University of Vienna, Waehringer Guertel 18-20, A-1090 Vienna, Austria, Tel.: +43 1 40400 5320, Fax: +43 1 40400 5321, E-mail: simon.panzer@meduniwien.ac.at.
    Abstract

    Data on the in vivo function of platelets induced by the thrombopoietin receptor agonist eltrombopag are scarce. To #$%$ a possible influence of eltrombopag we compared platelet function of eltrombopag-treated immune thrombocytopenia (ITP) patients (group 1; n=10) after treatment response to that from control ITP patients (group 2; n=12). We further analysed platelet function at baseline and after one, three, and four weeks of eltrombopag treatment and estimated daily changes of platelet function during the eltrombopag-induced platelet rise. The formation of platelet-monocyte aggregates (PMA), P-selectin expression [MFI], and platelet adhesion under high shear conditions (surface coverage, SC) in vivo and after in vitro addition of agonists (ADP, TRAP-6, Collagen) were similar between both groups after response to eltrombopag treatment. Only TRAP-6 induced a lower SC in the eltrombopag group (p=0.03). All platelet function parameters except for Collagen-induced P-selectin expression changed significantly during treatment with eltrombopag. PMA, naïve and after addition of ADP or TRAP-6 increased with increasing platelet counts. P-selectin expression decreased, when measured without and upon addition of ADP, increased in the presence of TRAP-6, and remained unchanged after addition of Collagen. SC increased during the eltrombopag-induced platelet rise. All significant changes of platelet function correlated to changes in platelet counts. Two patients developed venous thromboses during eltrombopag treatment, but no association with any distinct single platelet function parameter or combinations thereof was identifiable. Thus, eltrombopag-induced platelets function similar to those from control ITP patients without discernible increased hyper-reactivity.

 
LGND
52.13+0.090(+0.17%)Dec 18 4:00 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
BlackBerry Limited
NASDAQThu, Dec 18, 2014 4:00 PM EST
Under Armour, Inc.
NYSEThu, Dec 18, 2014 4:03 PM EST
Orexigen Therapeutics, Inc.
NASDAQThu, Dec 18, 2014 4:00 PM EST